Literature DB >> 22186139

Myc posttranscriptionally induces HIF1 protein and target gene expression in normal and cancer cells.

Megan R Doe1, Janice M Ascano, Mandeep Kaur, Michael D Cole.   

Abstract

c-Myc is frequently overexpressed in tumors and plays an important role in the regulation of cancer metabolism. Hypoxia-inducible factor-1 (HIF1), the master regulator of the hypoxic response, enhances tumorigenesis and influences metabolism via upregulation of the glycolytic pathway and suppression of mitochondrial respiration. Together, deregulated Myc and HIF1 cooperate to lend metabolic advantages to proliferating cancer cells and contribute to the Warburg effect. Here we show that overexpression of Myc significantly stabilizes the α subunit of HIF1 (HIF1α) under normoxic conditions and enhances HIF1α accumulation under hypoxic conditions in cells. Posttranscriptional regulation of HIF1α by Myc led to the induction of HIF1α gene targets. Normoxic HIF1α protein expression was also dependent on Myc. Functionally, HIF1α expression was required for Myc-induced anchorage-independent growth and cell proliferation. Myc-dependent stabilization of HIF1α involved either disruption of binding to the VHL complex or posttranslational protein modifications. Taken together, our findings uncover a previously uncharacterized regulatory relationship between Myc and HIF1 that has important implications for cancer metabolism and development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22186139      PMCID: PMC3288382          DOI: 10.1158/0008-5472.CAN-11-2371

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  Mechanisms of transcriptional repression by Myc.

Authors:  D Kleine-Kohlbrecher; S Adhikary; M Eilers
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

3.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

Review 4.  Oxygen homeostasis.

Authors:  Gregg L Semenza
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 May-Jun

5.  Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor.

Authors:  P J Kallio; I Pongratz; K Gradin; J McGuire; L Poellinger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

6.  Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays.

Authors:  Jung-whan Kim; Karen I Zeller; Yunyue Wang; Anil G Jegga; Bruce J Aronow; Kathryn A O'Donnell; Chi V Dang
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

7.  Knockdown of hypoxia-inducible factor-1alpha in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate.

Authors:  Jing Li; Mingxia Shi; Ying Cao; Wensu Yuan; Tianxiang Pang; Bingzong Li; Zhao Sun; Lei Chen; Robert Chunhua Zhao
Journal:  Biochem Biophys Res Commun       Date:  2006-02-28       Impact factor: 3.575

8.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

Authors:  Zhizhong Li; Shideng Bao; Qiulian Wu; Hui Wang; Christine Eyler; Sith Sathornsumetee; Qing Shi; Yiting Cao; Justin Lathia; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

Review 9.  The interplay between MYC and HIF in cancer.

Authors:  Chi V Dang; Jung-whan Kim; Ping Gao; Jason Yustein
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

Review 10.  Energy regulation: HIF MXIes it up with the C-MYC powerhouse.

Authors:  Patrick D Sutphin; Amato J Giaccia; Denise A Chan
Journal:  Dev Cell       Date:  2007-06       Impact factor: 12.270

View more
  66 in total

Review 1.  Targeting the RhoGTPase/ROCK pathway for the treatment of VHL/HIF pathway-driven cancers.

Authors:  Jordan M Thompson; Jaime Landman; Olga V Razorenova
Journal:  Small GTPases       Date:  2017-07-07

Review 2.  The functional role of peroxiredoxin 3 in reactive oxygen species, apoptosis, and chemoresistance of cancer cells.

Authors:  Lianqin Li; Ai-Qun Yu
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-21       Impact factor: 4.553

3.  Bromodomain and hedgehog pathway targets in small cell lung cancer.

Authors:  Gurmeet Kaur; Russell A Reinhart; Anne Monks; David Evans; Joel Morris; Eric Polley; Beverly A Teicher
Journal:  Cancer Lett       Date:  2015-12-10       Impact factor: 8.679

4.  Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.

Authors:  Aik T Ooi; Brigitte N Gomperts
Journal:  Clin Cancer Res       Date:  2015-04-02       Impact factor: 12.531

5.  Transcriptomic Differences between Primary Colorectal Adenocarcinomas and Distant Metastases Reveal Metastatic Colorectal Cancer Subtypes.

Authors:  Yasmin Kamal; Stephanie L Schmit; Hannah J Hoehn; Christopher I Amos; H Robert Frost
Journal:  Cancer Res       Date:  2019-06-25       Impact factor: 12.701

6.  Tip110 Regulates the Cross Talk between p53 and Hypoxia-Inducible Factor 1α under Hypoxia and Promotes Survival of Cancer Cells.

Authors:  Khalid Amine Timani; Ying Liu; Yan Fan; Khalid S Mohammad; Johnny J He
Journal:  Mol Cell Biol       Date:  2015-05-04       Impact factor: 4.272

7.  A concerted metabolic shift in early forebrain alters the CSF proteome and depends on MYC downregulation for mitochondrial maturation.

Authors:  Ryann M Fame; Morgan L Shannon; Kevin F Chau; Joshua P Head; Maria K Lehtinen
Journal:  Development       Date:  2019-10-24       Impact factor: 6.868

8.  Hypoxia differentially regulates estrogen receptor alpha in 2D and 3D culture formats.

Authors:  Nathan A Whitman; Zhi-Wei Lin; Rachael M Kenney; Leonardo Albertini; Matthew R Lockett
Journal:  Arch Biochem Biophys       Date:  2019-06-01       Impact factor: 4.013

9.  The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4G.

Authors:  Columba de la Parra; Elisa Otero-Franqui; Michelle Martinez-Montemayor; Suranganie Dharmawardhane
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

10.  C-MYC, HIF-1α, ERG, TKT, and GSTP1: an Axis in Prostate Cancer?

Authors:  L Boldrini; R Bartoletti; M Giordano; F Manassero; C Selli; M Panichi; L Galli; F Farci; P Faviana
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.